関連する実験動画
Updated: Jun 25, 2026

09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
癌の診断における核医学
1Division of Nuclear Medicine, University of Washington Medical Center, Seattle 98195-6113, USA. jeary@u.washington.edu
Lancet (London, England)
|September 15, 1999
まとめ
核医学イメージングは,がんの診断と治療計画に役立ちます. それは,ステージ設定,応答評価,および副作用の最小限の再発検出のための非侵襲的,繰り返し可能な評価を提供しています.
科学分野:
- 腫瘍学 腫瘍学
- 核医学は,核医学である.
- メディカルイマージング (医学イメージング)
背景:
- 核医学イメージングは,1970年代以来,がん治療において重要な役割を果たしてきました.
- 骨スキャンのような診断ツールは,高感度のため,腫瘍学で広く使用されています.
研究 の 目的:
- 癌患者の管理における核医学の役割を検討する.
- ステージ設定,治療計画,応答評価におけるその応用を強調する.
主な方法:
- 腫瘍学における診断アプリケーションのレビュー.
- ステージ,再ステージ,および治療反応のモニタリングのための非侵襲的イメージングに焦点を当てます.
主要な成果:
- 核医学は,がんのステージと再ステージの決定的な非侵襲的なデータを提供します.
- 治療への反応と疾患再発の効果的かつ繰り返し可能なモニタリングを可能にします.
結論:
- 核医学イメージングは,がん患者の総合的な管理に不可欠です.
- 腫瘍を特徴づけ,治療への反応を予測する能力は急速に進歩しています.
関連する概念動画
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

